Compare SYY & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SYY | HLN |
|---|---|---|
| Founded | 1969 | 2022 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Food Distributors | Package Goods/Cosmetics |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.2B | 43.7B |
| IPO Year | 2003 | N/A |
| Metric | SYY | HLN |
|---|---|---|
| Price | $81.14 | $10.06 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 1 |
| Target Price | ★ $89.77 | N/A |
| AVG Volume (30 Days) | 2.5M | ★ 8.3M |
| Earning Date | 04-28-2026 | 02-26-2026 |
| Dividend Yield | ★ 2.65% | 1.77% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.80 | N/A |
| Revenue | ★ $81,370,000,000.00 | N/A |
| Revenue This Year | $4.85 | $7.04 |
| Revenue Next Year | $4.97 | $4.58 |
| P/E Ratio | ★ $45.38 | $49.05 |
| Revenue Growth | ★ 3.20 | N/A |
| 52 Week Low | $67.12 | $8.71 |
| 52 Week High | $91.85 | $11.42 |
| Indicator | SYY | HLN |
|---|---|---|
| Relative Strength Index (RSI) | 32.98 | 40.69 |
| Support Level | $79.05 | $9.98 |
| Resistance Level | $82.62 | $10.31 |
| Average True Range (ATR) | 1.64 | 0.15 |
| MACD | -0.83 | -0.03 |
| Stochastic Oscillator | 5.38 | 14.30 |
Sysco is the largest US foodservice distributor with 17% share of the highly fragmented $370 billion domestic market. It distributes roughly 500,000 food and nonfood products to restaurants (60% of fiscal 2025 revenue), education and government buildings (8%), healthcare facilities (8%), travel and leisure (7%), and other locations (17%) where individuals consume away-from-home meals. In fiscal 2025, 70% of the firm's revenue was derived from its US foodservice operations, while its international (18%), quick-service logistics (10%), and other (2%) segments contributed the rest.
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.